Yahoo
Frankfurt - Delayed Quote EUR

Sarepta Therapeutics, Inc. (AB3A.F)

15.16 -0.58 (-3.68%)
As of 8:02:13 AM GMT+1. Market Open.
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Assets
3,349,703 3,963,173 3,264,576 3,128,366
Total Liabilities
2,209,081 2,435,431 2,405,239 2,743,416
Total Equity
1,140,622 1,527,742 859,337 384,950
Balance Sheet, Supplemental
Debt Maturity Schedule Total
828,974 1,137,124 1,237,998 1,544,292
Operating Lease Obligation Maturity Schedule Total
210,574 205,746 158,810 73,067
Total Debt
1,039,745 1,343,070 1,396,808 1,617,359
Net Debt
100,095 -11,722 -279,442 -372,015
Working Capital
1,442,648 2,341,779 1,925,672 1,938,257
Invested Capital
2,180,367 2,870,812 2,256,145 2,002,309
Tangible Book Value
1,111,673 1,500,855 829,717 377,372
Common Equity Book Value
1,140,622 1,527,742 859,337 384,950
12/31/2022 - 8/22/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: